Locations
Tel Aviv-Yafo, Israel · Ezor Tel Aviv, Israel
industry
Biotechnology · Data and Analytics · DeepTech · Design · Health
Size
11-50 employees
Stage
Seed
founded in
2020
Eleven Therapeutics is a biotechnology company focused on developing next-generation RNA therapeutics using synthetic chemistry and AI. Founded in 2020, the company aims to create scalable processes for programming RNA therapies, initially targeting respiratory diseases. Their innovative platform utilizes massively parallel combinatorial chemistry and AI algorithms to optimize RNA molecules for safety, efficiency, and duration of effect. With collaborative hubs in Cambridge, Boston, and Tel Aviv, Eleven Therapeutics partners with leading institutions to advance their mission of creating precise, durable therapeutics that address the root causes of diseases.
Is this your company?
Something looks off?